Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I
Overview
Authors
Affiliations
Objective: To examine the distribution of quantitative autistic traits (QATs) in an independent neurofibromatosis type I (NF1) sample, the relationships between QAT, sex, and attention deficit hyperactivity disorder (ADHD) symptomatology, and to explore evidence for QAT mutational specificity within families.
Study Design: Age-appropriate versions of the Social Responsiveness Scale, second edition and the Conners Adult ADHD Rating Scales were completed for 103 patients with NF1 from the Washington University Neurofibromatosis Center.
Results: Patients with NF1 exhibited a pathologically shifted unimodal distribution for QAT. Forty-four percent of the subjects exhibited a QAT burden at or above 1 SD from the population mean; 13% scored at or above the extreme first percentile of the general population distribution. Elevations in ADHD symptomatology exhibited a distinct bimodal distribution; however, mean ADHD index scores were equivalent in patients who had been diagnosed in the community with ADHD compared with those who had not. We observed striking within-family associations for QAT, reflected by an Social Responsiveness Scale, second edition intraclass correlation of 0.77 in pairings of first degree relatives with NF1.
Conclusions: Impairments in reciprocal social behavior and attention affect a large proportion of patients with NF1 throughout life and are often clinically unrecognized. Further exploration of genotype-phenotype correlation is strongly warranted for the purpose of gaining insights into mechanisms by which specific mutational variations in the NF1 gene may influence autistic trait severity.
Siqueiros-Sanchez M, Serur Y, McGhee C, Smith T, Green T Biol Psychiatry. 2024; 97(5):461-498.
PMID: 39366539 PMC: 11805629. DOI: 10.1016/j.biopsych.2024.09.019.
Omana Suarez G, Kumar D, Brunner H, Emel J, Teel J, Knauss A bioRxiv. 2024; .
PMID: 39149363 PMC: 11326213. DOI: 10.1101/2024.08.08.607070.
Autism spectrum disorder profiles in RASopathies: A systematic review.
Debbaut E, Steyaert J, El Bakkali M Mol Genet Genomic Med. 2024; 12(4):e2428.
PMID: 38581124 PMC: 10997847. DOI: 10.1002/mgg3.2428.
Wegscheid M, Anastasaki C, Hartigan K, Cobb O, Papke J, Traber J Cell Rep. 2021; 36(1):109315.
PMID: 34233200 PMC: 8278229. DOI: 10.1016/j.celrep.2021.109315.
Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.
Janusz J, Klein-Tasman B, Payne J, Wolters P, Thompson H, Martin S Neurology. 2021; 97(7 Suppl 1):S73-S80.
PMID: 34230205 PMC: 8594002. DOI: 10.1212/WNL.0000000000012422.